Why the study?
Repetitive DFT testing is the only way to verify ICD function in children with NT-ICD but is potentially harmful, motivating the analysis of testing data to prospectively predict individual DFT.
Can noninvasive parameters accurately predict defibrillation threshold ≥25 J in pediatric patients with nontransvenous implantable cardioverter defibrillators?
Can noninvasive parameters accurately predict defibrillation threshold ≥25 J in pediatric patients with nontransvenous implantable cardioverter defibrillators?
Serial DFT testing remains necessary and safe in children with NT-ICDs, as noninvasive prediction of high defibrillation thresholds shows only moderate accuracy.
No takes yet. Share an insight, caveat, or question.
Serial DFT testing detects NT-ICD failures safely in growing children; leaves open whether routine testing improves outcomes.
Backhoff et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: